Pediatric heart transplant candidates have the highest wait-list mortality of all organ candidates. Mechanical circulatory support has improved survival for many patients awaiting transplant. Biventricular mechanical circulatory support remains a particular challenge for pediatric patients. We present the smallest patient (body surface area 0.9 m2) to date to receive the 50 cc SynCardia Total Artificial Heart, supported for 278 days before successful heart transplant.
Purpose: Neurologic complications after heart transplantation (HT) have been reported to occur in greater than 50% of adult HT recipients, but their prevalence and relationship to pre-and peri-transplant conditions remains unclear. We aim to characterize early neurological complications after HT. Methods: We conducted a single center retrospective review of 355 HTs (5 re-transplants) performed at our hospital from late 1994-2014 for the following neurologic complications occurring in the first year after HT: Posterior reversible encephalopathy syndrome (PRES); hemorrhagic or embolic stroke; and isolated seizures. PRES was confirmed by brain MRI in all cases. Univariate and multivariate analysis was done in aggregate. Each individual neurologic complication was analyzed for their relationship to pre and peritransplant conditions, as well as risk of graft loss in the first year after HT. Results: Median age at the time of HT was 5.8 years. 55/355 (15.4%) experienced some neurological event, with PRES comprising 9/55 (16.3%); stroke 28/55 (50.9%); and isolated seizure 18/55 (33.7%). Median time to initial symptoms was 5 days (IQR 3-20 days). Initial symptom was seizure (56%), change in neurologic examination (14%), headache (11%), mental status changes (12%), and other (7%). Multivariate analysis revealed drugtreated hypertension was associated with PRES (OR 7.14, 95% CI 1.69-49.25, p= 0.007) and pre-HT support with ECMO was associated with stroke (OR 5.07, 95% CI 1.52-16.84, p= 0.0014). Isolated seizure was associated with cyclosporine use on univariate analysis (OR 3.86, 95% CI 1.32-11.21, p= 0.0081), but not on multivariate analysis. The presence of any neurologic complication was associated with an increased risk for mortality (OR 2.44, 95% CI 1.09-5.34, p= 0.0306) in the first year after HT. Conclusion: Neurologic complications occur relatively frequently in the first year after pediatric HT. They tend to occur in the first few weeks and are associated with an increased risk for 12 month mortality. Specific neurologic complications demonstrate specific risk profiles that may be amenable to early interventions to reduce risk. Further study in a larger sample size is needed to confirm and extend these findings.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.